Identification of a putative transactivation domain in human Nanog
about
Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesAlternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells.Nanog signaling in cancer promotes stem-like phenotype and immune evasionRequirement of Nanog dimerization for stem cell self-renewal and pluripotencyThe pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cellsTargeting cancer stem cells: emerging role of Nanog transcription factorNANOG: a promising target for digestive malignant tumorsStem cell transcription factor NANOG in cancers--is eternal youth a curse?Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.Two potent transactivation domains in the C-terminal region of human NANOG mediate transcriptional activation in human embryonic carcinoma cells.Characterization of Danio rerio Nanog and functional comparison to Xenopus Vents.Protein chip analysis of pluripotency-associated proteins in NIH3T3 fibroblast.A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.Molecular characterization of the human NANOG protein.
P2860
Q28540510-EF21253A-E271-473A-B6AA-A4B0252E3706Q35604846-9B46232F-D445-43A4-B845-0C441C75432CQ36357895-2B761C6F-8A3C-4F6D-8EEF-A377CA521B66Q36609095-DA522C6F-63B1-43DE-8618-EB2A29EB35ABQ36891700-35526492-1F8F-447C-B584-938B321A767BQ37170030-B2289619-6065-4E4A-8E98-6EAA3B09AE06Q38256341-490FD651-5C21-4F4B-9189-F6ED3E54D9F3Q38658623-060EC693-5D9C-47A8-B588-BA8F263E8791Q39221235-72A22878-30D9-4FD2-8B41-B8DFA80BC248Q39709744-87C3E088-C5DC-4A65-86BC-2C781F3D0DD6Q39881780-59D4C43A-A4F1-4082-8C6E-420E134D5D94Q42062875-29D715AC-9A6D-4204-B39E-BDFA813C8D40Q42834501-5FC13CF9-7364-4EEE-A9D1-B238B4F454B7Q43211406-A7EC15D7-7DDC-40E5-8DA3-DB972A88812AQ44276487-5CA1CC76-9B25-44CF-91D5-C4D6B4CA675B
P2860
Identification of a putative transactivation domain in human Nanog
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification of a putative transactivation domain in human Nanog
@ast
Identification of a putative transactivation domain in human Nanog
@en
Identification of a putative transactivation domain in human Nanog
@nl
type
label
Identification of a putative transactivation domain in human Nanog
@ast
Identification of a putative transactivation domain in human Nanog
@en
Identification of a putative transactivation domain in human Nanog
@nl
prefLabel
Identification of a putative transactivation domain in human Nanog
@ast
Identification of a putative transactivation domain in human Nanog
@en
Identification of a putative transactivation domain in human Nanog
@nl
P2093
P356
P1476
Identification of a putative transactivation domain in human Nanog
@en
P2093
Heung-Mo Yang
Hyun-Jin Do
Hyung-Min Chung
Jae-Hwan Kim
Jong-Hyun Oh
Kwang-Yul Cha
Shin-Yong Moon
P2888
P356
10.1038/EMM.2005.33
P407
P577
2005-06-30T00:00:00Z
P5875
P6179
1006468224